Trastuzumab 600mg
| Product Overview | |
| Generic Name | Trastuzumab 600mg |
| Brand Name(s) | Herceptin |
| Form | Intravenous infusion formulations—lyophilized powder or solution |
| Strength | 600 mg |
| Therapeutic Class | Monoclonal antibody targeting HER2/neu (antineoplastic/immunomodulator) |
| ATC Code | L01FD01 |
| Manufacturing & Regulatory | |
| Manufacturer | Roche/Genentech |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | Batch-specific |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 100 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
Description
Cofepris approvals to Zydus Lifesciences Ltd (Mamitra)
